|Other Names||Exocyst complex component 4, Exocyst complex component Sec8, EXOC4, KIAA1699, SEC8, SEC8L1|
|Target/Specificity||The synthetic peptide sequence is selected from aa 239-253 of HUMAN EXOC4|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Synonyms||KIAA1699, SEC8, SEC8L1|
|Function||Component of the exocyst complex involved in the docking of exocytic vesicles with fusion sites on the plasma membrane.|
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Component of the exocyst complex involved in the docking of exocytic vesicles with fusion sites on the plasma membrane.
Sha J.H.,et al.Submitted (MAY-2001) to the EMBL/GenBank/DDBJ databases.
Ota T.,et al.Nat. Genet. 36:40-45(2004).
Bechtel S.,et al.BMC Genomics 8:399-399(2007).
Scherer S.W.,et al.Science 300:767-772(2003).
Hillier L.W.,et al.Nature 424:157-164(2003).
If you have any additional inquiries please email technical services at firstname.lastname@example.org.